Starton Therapeutics to Present at BIO CEO & Investor

PARAMUS, N.J., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company focused...

Related Keywords

New York ,United States ,Pedro Lichtinger ,Starton Therapeutics Inc ,Chief Executive Officer ,Starton Therapeutics ,New York City ,Continuous Delivery Platform ,Improve Patient Outcomes ,Multiple Myeloma ,Chronic Lymphocytic Leukemia ,Biotechnology ,Tarton ,Tandard Of Care Therapies ,Tar Lld ,